Access to medication-assisted treatment in the United States: Comparison of travel time to opioid treatment programs and office-based buprenorphine treatment-Reference-Cited by-同舟云学术

Access to medication-assisted treatment in the United States: Comparison of travel time to opioid treatment programs and office-based buprenorphine treatment

Published:2021-07 Issue: Volume:224 Page:108727
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Amiri Solmaz,Hirchak Katherine,McDonell Michael G.^ORCID,Denney Justin T.,Buchwald Dedra,Amram Ofer

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference29 articles.

1. Geographic disparities in availability of opioid use disorder treatment for medicaid enrollees;Abraham;Health Serv. Res.,2018

2. Increased distance was associated with lower daily attendance to an opioid treatment program in Spokane County Washington;Amiri;J. Subst. Abuse Treat.,2018

3. Spatial access to opioid treatment program and alcohol and cannabis outlets: analysis of missed doses of methadone during the first, second, and third 90 days of treatment;Amiri;Am. J. Drug Alcohol Abuse,2019

4. Disparities in access to opioid treatment programs and office-based buprenorphine treatment across the rural-urban and area deprivation continua: a US Nationwide small area analysis;Amiri;Value Health,2020

5. Prescribing practices of rural physicians waivered to prescribe buprenorphine;Andrilla;Am. J. Prev. Med.,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Affordable transportation access to treatment for opioid use disorder;Transport Policy;2024-09

2. Accessibility of Opioid Treatment Programs Based on Conventional vs Perceived Travel Time Measures;JAMA Network Open;2024-02-20

3. Disparities in access to opioid treatment programs and buprenorphine providers by race and ethnicity in the contiguous U.S.;Journal of Substance Use and Addiction Treatment;2024-01

4. Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US;Harm Reduction Journal;2023-12-21

5. Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy;Substance Abuse;2023-10